These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 28677106)
21. [Correlative study of distribution of brain tumor stem cell with micro-vascular system]. Li MW; Niu CS Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(5):305-9. PubMed ID: 20368050 [TBL] [Abstract][Full Text] [Related]
22. The significance of the expression of tumor suppressor gene DCC in human gliomas. Nakatani K; Yoshimi N; Mori H; Sakai H; Shinoda J; Andoh T; Sakai N J Neurooncol; 1998 Dec; 40(3):237-42. PubMed ID: 10066096 [TBL] [Abstract][Full Text] [Related]
23. Expression of NANOG in human gliomas and its relationship with undifferentiated glioma cells. Niu CS; Li DX; Liu YH; Fu XM; Tang SF; Li J Oncol Rep; 2011 Sep; 26(3):593-601. PubMed ID: 21573506 [TBL] [Abstract][Full Text] [Related]
24. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth. Di K; Linskey ME; Bota DA Oncogene; 2013 Oct; 32(42):5038-47. PubMed ID: 23178488 [TBL] [Abstract][Full Text] [Related]
25. Overexpression of Roundabout4 predicts poor prognosis of primary glioma patients via correlating with microvessel density. Cai H; Xue Y; Liu W; Li Z; Hu Y; Li Z; Shang X; Liu Y J Neurooncol; 2015 May; 123(1):161-9. PubMed ID: 25859844 [TBL] [Abstract][Full Text] [Related]
26. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas. Guo Y; Liu S; Wang P; Zhao S; Wang F; Bing L; Zhang Y; Ling EA; Gao J; Hao A Histopathology; 2011 Oct; 59(4):763-75. PubMed ID: 22014056 [TBL] [Abstract][Full Text] [Related]
27. Overexpression of CD44 is associated with a poor prognosis in grade II/III gliomas. Hou C; Ishi Y; Motegi H; Okamoto M; Ou Y; Chen J; Yamaguchi S J Neurooncol; 2019 Nov; 145(2):201-210. PubMed ID: 31506754 [TBL] [Abstract][Full Text] [Related]
28. In vivo expression of insulin-like growth factor-binding protein-2 in human gliomas increases with the tumor grade. Elmlinger MW; Deininger MH; Schuett BS; Meyermann R; Duffner F; Grote EH; Ranke MB Endocrinology; 2001 Apr; 142(4):1652-8. PubMed ID: 11250947 [TBL] [Abstract][Full Text] [Related]
29. Deregulated expression of cry1 and cry2 in human gliomas. Luo Y; Wang F; Chen LA; Chen XW; Chen ZJ; Liu PF; li FF; Li CY; Liang W Asian Pac J Cancer Prev; 2012; 13(11):5725-8. PubMed ID: 23317246 [TBL] [Abstract][Full Text] [Related]
30. CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays. He J; Liu Y; Zhu T; Zhu J; Dimeco F; Vescovi AL; Heth JA; Muraszko KM; Fan X; Lubman DM Mol Cell Proteomics; 2012 Jun; 11(6):M111.010744. PubMed ID: 22203689 [TBL] [Abstract][Full Text] [Related]
31. cMYC expression in infiltrating gliomas: associations with IDH1 mutations, clinicopathologic features and outcome. Odia Y; Orr BA; Bell WR; Eberhart CG; Rodriguez FJ J Neurooncol; 2013 Nov; 115(2):249-59. PubMed ID: 23934175 [TBL] [Abstract][Full Text] [Related]
33. Overexpression of cytosolic, plasma membrane bound and extracellular heat shock protein 70 (Hsp70) in primary glioblastomas. Thorsteinsdottir J; Stangl S; Fu P; Guo K; Albrecht V; Eigenbrod S; Erl J; Gehrmann M; Tonn JC; Multhoff G; Schichor C J Neurooncol; 2017 Dec; 135(3):443-452. PubMed ID: 28849427 [TBL] [Abstract][Full Text] [Related]
34. Differential patterns of NOTCH1-4 receptor expression are markers of glioma cell differentiation. Dell'albani P; Rodolico M; Pellitteri R; Tricarichi E; Torrisi SA; D'Antoni S; Zappia M; Albanese V; Caltabiano R; Platania N; Aronica E; Catania MV Neuro Oncol; 2014 Jan; 16(2):204-16. PubMed ID: 24305720 [TBL] [Abstract][Full Text] [Related]
35. B7-H4 expression is elevated in human U251 glioma stem-like cells and is inducible in monocytes cultured with U251 stem-like cell conditioned medium. Mo LJ; Ye HX; Mao Y; Yao Y; Zhang JM Chin J Cancer; 2013 Dec; 32(12):653-60. PubMed ID: 23327799 [TBL] [Abstract][Full Text] [Related]
36. Differential expression of stem cell markers in proliferating cells in glioma. Rehfeld M; Matschke J; Hagel C; Willenborg K; Glatzel M; Bernreuther C J Cancer Res Clin Oncol; 2021 Oct; 147(10):2969-2982. PubMed ID: 34170383 [TBL] [Abstract][Full Text] [Related]
37. A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma. Patil V; Mahalingam K Gene; 2018 Dec; 679():57-64. PubMed ID: 30077762 [TBL] [Abstract][Full Text] [Related]
38. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas. Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164 [TBL] [Abstract][Full Text] [Related]
39. Glycosilated nucleolin as marker for human gliomas. Galzio R; Rosati F; Benedetti E; Cristiano L; Aldi S; Mei S; D'Angelo B; Gentile R; Laurenti G; Cifone MG; Giordano A; Cimini A J Cell Biochem; 2012 Feb; 113(2):571-9. PubMed ID: 21938743 [TBL] [Abstract][Full Text] [Related]
40. Endothelin B receptor expression in malignant gliomas: the perivascular immune escape mechanism of gliomas. Nakashima S; Sugita Y; Miyoshi H; Arakawa F; Muta H; Ishibashi Y; Niino D; Ohshima K; Terasaki M; Nakamura Y; Morioka M J Neurooncol; 2016 Mar; 127(1):23-32. PubMed ID: 26645886 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]